NUROGLOW Trademark

Trademark Overview


On Monday, June 13, 2022, a trademark application was filed for NUROGLOW with the United States Patent and Trademark Office. The USPTO has given the NUROGLOW trademark a serial number of 97454709. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, May 12, 2023. This trademark is owned by ALUME BIOSCIENCES, INC.. The NUROGLOW trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for therapeutic or diagnostic use in surgical or medical procedures; Pharmaceutical preparations for fluorescence image-guided surgery; Pharmaceutical preparations, namely, target-specific peptide conjugates, for use in surgical and medical procedures; Pharmaceutical preparations in the nature of peptide conjugate preparations for image-guided surgery; Pharmaceutical preparations for illuminating nerves or other structures during a surgical or medical procedure; Pharmaceutical preparations in the nature of nerve-targeting peptides for use in surgical and medical procedures; Pharmaceutical preparations employing targeting peptide conjugates for use in visualizing nerves during surgical or medical procedures; Pharmaceutical preparations for use in surgical procedures, namely, to help avoid nerve damage or to facilitate targeted nerve ablation; Pharmaceutical preparations for illuminating, labeling, tagging, or targeting nerves or ureters
nuroglow

General Information


Serial Number97454709
Word MarkNUROGLOW
Filing DateMonday, June 13, 2022
Status601 - ABANDONED - EXPRESS
Status DateFriday, May 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for therapeutic or diagnostic use in surgical or medical procedures; Pharmaceutical preparations for fluorescence image-guided surgery; Pharmaceutical preparations, namely, target-specific peptide conjugates, for use in surgical and medical procedures; Pharmaceutical preparations in the nature of peptide conjugate preparations for image-guided surgery; Pharmaceutical preparations for illuminating nerves or other structures during a surgical or medical procedure; Pharmaceutical preparations in the nature of nerve-targeting peptides for use in surgical and medical procedures; Pharmaceutical preparations employing targeting peptide conjugates for use in visualizing nerves during surgical or medical procedures; Pharmaceutical preparations for use in surgical procedures, namely, to help avoid nerve damage or to facilitate targeted nerve ablation; Pharmaceutical preparations for illuminating, labeling, tagging, or targeting nerves or ureters

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALUME BIOSCIENCES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Friday, May 12, 2023ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Friday, May 12, 2023ABANDONMENT - EXPRESS MAILED
Thursday, May 11, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, April 27, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, April 11, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, March 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 25, 2023ASSIGNED TO EXAMINER
Thursday, June 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 16, 2022NEW APPLICATION ENTERED